KRBA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.974200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.023600E-01
Normal-vs-Stage2
1.150360E-02
Normal-vs-Stage3
1.145820E-01
Normal-vs-Stage4
2.579200E-01
Stage1-vs-Stage2
1.550000E-01
Stage1-vs-Stage3
4.519900E-02
Stage1-vs-Stage4
3.574000E-01
Stage2-vs-Stage3
1.438030E-01
Stage2-vs-Stage4
6.977000E-01
Stage3-vs-Stage4
2.527000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.110800E-01
Normal-vs-AfricanAmerican
8.719900E-02
Normal-vs-Asian
1.293840E-02
Caucasian-vs-AfricanAmerican
9.081800E-01
Caucasian-vs-Asian
2.988000E-01
AfricanAmerican-vs-Asian
3.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.012300E-02
Normal-vs-Female
1.944020E-01
Male-vs-Female
3.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.542600E-01
Normal-vs-Age(41-60Yrs)
3.027800E-01
Normal-vs-Age(61-80Yrs)
2.836000E-02
Normal-vs-Age(81-100Yrs)
1.382410E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.700000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.253600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.668400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.681800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.721700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.372100E-02
Normal-vs-Daily Drinker
3.501400E-03
Normal-vs-Weekly Drinker
1.429910E-02
Normal-vs-Occasional Drinker
2.937800E-01
Normal-vs-Social Drinker
8.965600E-01
Non Drinker-vs-Daily Drinker
1.925850E-01
Non Drinker-vs-Weekly Drinker
7.529400E-01
Non Drinker-vs-Occasional Drinker
2.726000E-01
Non Drinker-vs-Social Drinker
9.151900E-02
Daily Drinker-vs-Weekly Drinker
3.810800E-01
Daily Drinker-vs-Occasional Drinker
5.780400E-02
Daily Drinker-vs-Social Drinker
3.568200E-02
Weekly Drinker-vs-Occasional Drinker
2.002600E-01
Weekly Drinker-vs-Social Drinker
7.421900E-02
Occasional Drinker-vs-Social Drinker
3.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.557200E-01
Normal-vs-Grade 2
2.402400E-01
Normal-vs-Grade 3
1.703820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.982000E-02
Grade 1-vs-Grade 3
2.273200E-01
Grade 1-vs-Grade 4
3.557200E-01
Grade 2-vs-Grade 3
1.261790E-01
Grade 2-vs-Grade 4
2.402400E-01
Grade 3-vs-Grade 4
1.703820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.784300E-03
Normal-vs-NonDiabetic
1.321380E-01
Diabetic-vs-NonDiabetic
2.948600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.112250E-02
Normal-vs-NoPancreatitis
1.100630E-01
Pancreatitis-vs-NoPancreatitis
2.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.334800E-01
Normal-vs-N1
1.279920E-02
N0-vs-N1
2.298600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.554050E-01
Normal-vs-TP53-NonMutant
5.245400E-01
TP53-Mutant-vs-TP53-NonMutant
1.75859000000056E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
